E-DRUG: Update to Optimal & Limited-Use Lists of Paediatric ARV Formulations
---------------------------------------------------------------------------------
Dear E-Drug members,
Pediatric patients remain among the most challenging to treat.
The Inter-Agency Task Team (IATT) on the Prevention and Treatment of HIV
Infection in Pregnant Women, Mothers and Children and other groups is
focused on meeting the needs of these vulnerable children.The IATT has
published an update to the Optimal and Limited-Use Paediatric ARV
Formularies, for use by governments and implementing agencies. The lists
provide guidance on optimal products that are most readily available on the
market and comply with WHO treatment guidance. The IATT works with WHO and
UNICEF to periodically review and update these formularies.
The 2015 Update of the Optimal List may be accessed here:
http://www.emtct-iatt.org/wp-content/uploads/2015/05/Updated-Formulary-04012015.pdf
The Updated formulary includes contacts points for further information if required.
Kind regards
David Jamieson
Mr. David G JAMIESON
Deputy Director, Project Planning and Global Partnerships
Supply Chain Management System (SCMS)
Partnership for Supply Chain Management (PFSCM)
1616 Fort Myer Drive, 12th Floor
Arlington, VA 22209 USA
Email: djamieson@pfscm.org